Silo Pharma, Inc. (SILO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 6.8M | 7.39M | 6.16M | 6.37M | 5.6M | 7.11M | 8.26M | 7.73M | 6.88M | 7.68M | 8.92M | 10.18M |
| Cash & Short-Term Investments | 6.27M | 6.86M | 5.94M | 6.26M | 5.45M | 7.08M | 8.02M | 7.61M | 6.74M | 7.67M | 8.77M | 9.99M |
| Cash Only | 3.9M | 4.75M | 3.92M | 4.33M | 3.14M | 3.91M | 4.86M | 4.51M | 2.67M | 3.52M | 199.84K | 158.83K |
| Short-Term Investments | 2.37M | 2.11M | 2.02M | 1.93M | 2.31M | 3.17M | 3.15M | 3.1M | 4.08M | 4.14M | 8.57M | 9.83M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69.6K | 68.39K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | 352.15 | 342.25 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 529.39K | 528.96K | 225.88K | 113.06K | 152.73K | 30.96K | 246.45K | 120.29K | 133.76K | 15.97K | 79.91K | 121.33K |
| Total Non-Current Assets | 214.44K | 217.38K | 220.31K | 279.48K | 295.81K | 300.36K | 304.91K | 309.46K | 63.52K | 64.98K | 66.44K | 67.9K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 214.44K | 217.38K | 220.31K | 223.25K | 238.12K | 241.22K | 244.31K | 247.4K | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | -1 | 56.23K | 57.69K | 59.15K | 60.6K | 62.06K | 63.52K | 64.98K | 66.44K | 67.9K |
| Total Assets | 7.02M | 7.61M | 6.38M | 6.65M | 5.9M | 7.41M | 8.57M | 8.04M | 6.94M | 7.75M | 8.99M | 10.25M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | 18.95% | 2.61% | -25.47% | -17.24% | -15% | -4.32% | -4.68% | -21.54% | -37.03% | -33.47% | -31.13% | 13.28% |
| Total Current Liabilities | 704.85K | 650.18K | 708.34K | 1.05M | 1.19M | 1.66M | 1.04M | 1.32M | 873.67K | 775.59K | 678.77K | 1.12M |
| Accounts Payable | 632.74K | 578.08K | 636.24K | 977.79K | 1.11M | 1.58M | 972.73K | 1.25M | 801.57K | 703.49K | 606.67K | 1.05M |
| Days Payables Outstanding | 204.64 | 2.7K | 3.59K | 65.21K | 83.13K | 294.11 | 70.1K | 64K | 46.9K | 41.28K | 52.17K | 53.28K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K | 72.1K |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 9.65x | 11.36x | 8.70x | 6.07x | 4.73x | 4.29x | 7.91x | 5.84x | 7.87x | 9.90x | 13.14x | 9.09x |
| Quick Ratio | 9.65x | 11.36x | 8.70x | 6.07x | 4.73x | 4.29x | 7.91x | 5.84x | 7.87x | 9.90x | 13.14x | 9.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 631.45K | 649.48K | 667.5K | 685.53K | 703.55K | 721.58K | 739.6K | 757.63K | 775.65K | 793.68K | 811.71K | 829.73K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.34M | 1.3M | 1.38M | 1.74M | 1.89M | 2.38M | 1.78M | 2.08M | 1.65M | 1.57M | 1.49M | 1.95M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -3.9M | -4.75M | -3.92M | -4.33M | -3.14M | -3.91M | -4.86M | -4.51M | -2.67M | -3.52M | -199.84K | -158.83K |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -487.32x | -25.96x | -1252.32x | -729.76x | -498.24x | -6548.36x | -858.22x | -500.23x | -427.70x | -3850.93x | -611.39x | -542.72x |
| Total Equity | 5.68M | 6.31M | 5.01M | 4.92M | 4.01M | 5.03M | 6.78M | 5.96M | 5.29M | 6.18M | 7.5M | 8.3M |
| Equity Growth % | 41.65% | 25.25% | -26.15% | -17.47% | -24.21% | -18.5% | -9.53% | -28.18% | -43.96% | -40.27% | -36.76% | 5.35% |
| Book Value per Share | 6.22 | 7.10 | 8.05 | 11.75 | 13.42 | 16.84 | 23.65 | 29.27 | 27.69 | 31.88 | 36.17 | 39.45 |
| Total Shareholders' Equity | 5.68M | 6.31M | 5.01M | 4.92M | 4.01M | 5.03M | 6.78M | 5.96M | 5.29M | 6.18M | 7.5M | 8.3M |
| Common Stock | 1.63K | 1.33K | 1.05K | 865 | 449 | 449 | 449 | 408 | 316 | 316 | 311 | 311 |
| Retained Earnings | -21.14M | -19.49M | -18.61M | -17.5M | -16.3M | -15.26M | -13.53M | -12.61M | -11.67M | -10.87M | -9.75M | -9.09M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | -6.27K | -644.23K | -586.57K | -471.12K | -161.94K | -16.2K |
| Accumulated OCI | 8.72K | 5.83K | 11.35K | 9.56K | 10.7K | 2.42K | 19.8K | 8.03K | 26.1K | -6.23K | -723 | -3.28K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |